Aerosolized Linear Polyethylenimine-Nitric Oxide/Nucleophile Adduct Attenuates Endotoxin-induced Lung Injury in Sheep
- 1 December 2002
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 166 (11) , 1436-1442
- https://doi.org/10.1164/rccm.2202021
Abstract
Pulmonary hypertension and edema are mainstays of acute lung injury (ALI). We synthesized linear polyethylenimine-nitric oxide/nucleophile adduct (DS-1), a water-soluble nitric oxide donor, and demonstrated that it is a potent relaxant of precontracted rat aortic rings without inducing desensitization. Moreover, DS-1 does not suppress the viability of human pulmonary epithelial cells in vitro. We also tested whether DS-1 counteracts ALI in endotoxemic sheep. Animals were instrumented for a chronic study. In 16 awake, spontaneously breathing sheep, Escherichia coli endotoxin (10 ng/kg/minute) was infused for 8 hours. From 2 hours of endotoxemia, sheep received either nebulized DS-1 (1 mg/kg/hour) or isotonic saline. DS-1 reduced endotoxin-induced rises in pulmonary arterial and microwedge pressures and vascular resistance index by 40-70%. In parallel, DS-1 decreased the accumulation of extravascular lung water by 60-70% and reduced the increment in right ventricle stroke work index and the falls in right ventricle ejection fraction, stroke volume, and left ventricle stroke work indices. Furthermore, DS-1 reduced venous admixture and improved arterial oxygen saturation. In four healthy animals, DS-1 alone slightly increased arterial oxygenation but had no other effects. Thus, aerosolized DS-1 attenuates endotoxin-induced ALI in sheep by reducing pulmonary hypertension and edema and improving myocardial function and gas exchange.Keywords
This publication has 42 references indexed in Scilit:
- Respiratory Deposition Patterns of Salbutamol pMDI with CFC and HFA-134a Formulations in a Human Airway ReplicaJournal of Aerosol Medicine, 2001
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Physiological and Pathological Considerations for Aerosol Deposition: Expiration and Models of DepositionJournal of Aerosol Medicine, 2000
- Aerosolized prostacyclin and inhaled nitric oxide in septic shock — different effects on splanchnic oxygenation?Intensive Care Medicine, 1996
- Delivery and monitoring of inhaled nitric oxideIntensive Care Medicine, 1996
- LEFT VENTRICULAR DYSFUNCTION AND ACUTE LUNG INJURY INDUCED BY CONTINUOUS ADMINISTRATION OF ENDOTOXIN IN SHEEPShock, 1994
- Selective Deposition of Inhaled Aerosols to Mechanically Ventilated RabbitsJournal of Aerosol Medicine, 1994
- Inhaled Nitric Oxide for the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1993
- Nitric Oxide/Nucleophile ComplexesJournal of Cardiovascular Pharmacology, 1993
- Pulmonary Vasodilator Effects of Nitroglycerin and Sodium Nitroprusside in Canine Oleic Acid-induced Pulmonary HypertensionAnesthesiology, 1983